SF 328 (see companion bill HF 294) – MinnesotaStatus: In Process
Year Introduced: 2023
This bill establishes requirements for reporting and maintaining prescription drug prices and requirements for transparency of prescription drug benefits. Article 1 requires health carriers to file drug formularies with the commissioner of commerce, requires drug manufacturers to report price and other information for certain drugs, and prohibits price increases for formulary drugs subject to reporting. Article 2 modifies requirements for electronic prescribing, establishes requirements for health plan companies to make available formularies and related benefit information, and establishes requirements for formulary changes made by health plan companies
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.